Compare RVMD & NVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVMD | NVR |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | United States | United States |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2B | 17.9B |
| IPO Year | N/A | 1995 |
| Metric | RVMD | NVR |
|---|---|---|
| Price | $146.92 | $6,033.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 5 |
| Target Price | $140.84 | ★ $7,157.80 |
| AVG Volume (30 Days) | ★ 3.7M | 14.0K |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 436.55 |
| Revenue | N/A | ★ $10,323,959,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $533.02 | $6.60 |
| P/E Ratio | ★ N/A | $13.79 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $34.00 | $5,930.00 |
| 52 Week High | $155.70 | $8,618.28 |
| Indicator | RVMD | NVR |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 33.79 |
| Support Level | $93.39 | N/A |
| Resistance Level | $152.85 | $7,778.36 |
| Average True Range (ATR) | 7.19 | 208.13 |
| MACD | -0.47 | -73.03 |
| Stochastic Oscillator | 61.79 | 6.52 |
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
NVR Inc is engaged in the construction and sale of residential properties, including single-family detached homes, townhomes, and condominium buildings, all of which are built on a pre-sold basis. Additionally, the company provides related services through its mortgage banking and title services businesses. Its business segments are Homebuilding and Mortgage Banking. Its geographical segments include the Mid Atlantic, the North East, the Mid East, and the South East regions of America. The majority of the company's revenue is derived from the Homebuilding Mid Atlantic segment, which includes homebuilding operations that construct and sell single-family detached homes, townhomes and condominiums in Maryland, Virginia, West Virginia, Delaware and Washington, D.C. regions.